"Designing Growth Strategies is in our DNA"

U.S. Brain Tumor Drugs Market Size, Share & COVID-19 Impact Analysis, By Therapy (Targeted Therapy, Chemotherapy, Immunotherapy, and Others), By Indication (Pituitary, Meningioma, Glioma, and Others), By Distribution Channel (Hospital Pharmacies and Retail & Online Pharmacies), and Country Forecast, 2023-2030

Last Updated: February 03, 2025 | Format: PDF | Report ID: FBI108123

 

  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
    4. Market Trends
  4. Key Insights
    1. Incidence of Brain Cancer
    2. Key Industry Developemnts: Mergers, Acquisitions, and Partnerships
    3. Overview of Regulatory Scenario
    4. New Product Launches by Key Players
    5. Impact of COVID-19 on the Market
  5. U.S. Brain Tumor Drugs Market Analysis, Insights and Forecast, 2019-2030
    1. Market Analysis, Insights and Forecast – By Therapy
      1. Targeted Therapy
      2. Chemotherapy
      3. Immunotherapy
      4. Others
    2. Market Analysis, Insights and Forecast – By Indication
      1. Pituitary
      2. Meningioma
      3. Glioma
      4. Others
    3. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail & Online Pharmacies
  6. Competitive Analysis
    1. U.S. Market Share Analysis (2022)
    2. Company Profiles
      1. F. Hoffmann-La Roche Ltd.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      2. Novartis AG
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      3. Merck & Co. Inc.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      4. Pfizer Inc.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      5. Amneal Pharmaceuticals LLC.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      6. Amgen Inc.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      7. NextSource Pharmaceuticals, LLC
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
    3. Other Prominent Players
Read Less

Figure 1: U.S. Brain Tumor Drugs Market Revenue Breakdown (USD Million, %), By Indication, 2022 & 2030

Figure 2: U.S. Brain Tumor Drugs Market Value Share (%), by Therapy, 2022 & 2030

Figure 3: U.S. Brain Tumor Drugs Market Value Share (%), by Indication, 2022 & 2030

Figure 4: U.S. Brain Tumor Drugs Market Value Share (%), by Distribution Channel, 2022 & 2030

Figure 5: U.S. Brain Tumor Drugs Market Share (%), By Company, 2022

Table 1: U.S. Brain Tumor Drugs Market Revenue (USD Million) Forecast, by Therapy, 2019–2030

Table 2: U.S. Brain Tumor Drugs Market Revenue (USD Million) Forecast, by Indication, 2019–2030

Table 3: U.S. Brain Tumor Drugs Market Revenue (USD Million) Forecast, by Distribution Channel, 2019–2030

U.S. Brain Tumor Drugs Market Size, Share and Global Industry Trend Forecast till 2030
  • 2019-2030
  • 2022
  • 2019-2021
  • 70
Multi-report Purchase Plan
    A Customized Plan Will be Created Based on the number of reports you wish to purchase